PDCD1 and metastatic melanoma: The aim of this study is to investigate the prognostic value of BLNLR combined with ΔNLR% in patients with metastatic melanoma treated with PD-1 inhibitors in the Chinese population, to stratify the prognosis of patients and to attempt to provide reference for clinical decision making of metastatic melanoma patients in China.